Table 1.
Patient characteristics
| Characteristic | Values |
|---|---|
| Age (year) | Median, 54 (range, 23–74) |
| Sex, n (%) | |
| Male | 29 (56.9%) |
| Female | 22 (43.1%) |
| WHO 2016 grade, n (%) | |
| Grade II | 10 (19.6%) |
| Grade III | 16 (31.4%) |
| Grade IV | 25 (49.0%) |
| Histology, n (IDH-mutant/wildtype) | (19/32) |
| Astrocytoma | 41 |
| Grade II | 5 (5/0) |
| Grade III | 11 (3/8) |
| Grade IV | 25 (1/24) |
| Oligodendroglioma | 10 |
| Grade II | 5 |
| Grade III | 5 |
| 1p/19q co-deletion (non/co-deletion) | 31/20 |
| SUV ratio (IQR 25%–75%) | |
| White matter | 4.83 (3.69–7.02) |
| Gray matter | 2.48 (1.63–3.32) |
| Choroid plexus | 1.65 (1.23–2.41) |
| Cerebellum | 2.29 (1.73–3.43) |
WHO, World Health Organization